What is the current Apheresis market size?

The Apheresis market size was valued at USD 1.2 billion in 2023, driven by increasing demand for blood component therapies and advancements in treatment technologies.

What is the Apheresis market growth forecast?

The market is projected to grow at a CAGR of 5.8% from 2024 to 2031, fueled by rising chronic disease prevalence and expansion in emerging economies.

What are the key drivers of the Apheresis market?

Key drivers include growing autoimmune disorder cases, rising organ transplant rates, and enhanced awareness of apheresis therapies for rare diseases.

What challenges does the Apheresis market face?

Challenges include high equipment costs, limited skilled professionals, and stringent regulatory requirements for device approvals.

Which regions lead the Apheresis market?

North America dominates the market, followed by Europe, due to advanced healthcare infrastructure and high adoption of apheresis technologies.

Who are the top companies in the Apheresis market?

Leading players include Fresenius Medical Care, Terumo BCT, and B. Braun Melsungen AG, which focus on R&D and strategic partnerships.

What future opportunities exist in the Apheresis market?

Opportunities lie in expanding applications for autoimmune treatments, cell therapy growth, and increasing demand in Asia-Pacific regions.

How is technology impacting the Apheresis market?

Advancements in automated systems, AI-driven diagnostics, and miniaturized devices are enhancing precision and patient outcomes in apheresis therapies.

What is the regulatory landscape for Apheresis?

Regulatory bodies like the FDA and EMA enforce strict guidelines for device safety and efficacy, ensuring compliance in global Apheresis market operations.

How will the Apheresis market evolve post-pandemic?

Post-pandemic, the market is expected to leverage telehealth integration and remote monitoring tools to improve accessibility and reduce hospital visits.

Apheresis Market: Opportunity by 2034 | In-Depth Report

Apheresis by Application (Renal Diseases, Neurology, Cancer, Hematology, Autoimmune Diseases), by Types (Centrifugation, Membrane Filtration), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $1584.1 million

CAGR: 4.4%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $1584.1 million

CAGR: 4.4%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Apheresis Market Overview

Apheresis is a medical procedure that separates blood components for therapeutic or diagnostic purposes, playing a critical role in treating autoimmune disorders, hematological conditions, and organ transplants. The Apheresis market size is poised for robust growth outlook through 2033, driven by advancements in automated systems and rising demand for personalized therapies. This market forecast underscores the industry expansion potential, with a focus on improving patient outcomes and reducing treatment costs. The study evaluates global trends, competitive dynamics, and regulatory frameworks shaping the Apheresis sector from 2021 to 2033.

Loading chart…

The global Apheresis market reached $4.2 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033. Key drivers include the adoption of closed-system apheresis devices to mitigate contamination risks and the expanding role of plasma-derived therapies in oncology. North America remains the largest market due to advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region, fueled by rising chronic disease prevalence and government investments in medical technology. Strategic collaborations among manufacturers and healthcare providers, alongside evolving reimbursement policies, are critical forces reshaping the industry landscape.

Report Overview

Report Attribute	Details
Market size value in 2025	1.58 billion
Revenue forecast in 2033	2.76 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Asahi Kasei Medical; Terumo Corporation; Haemonetics Corporation; Fresenius Kabi; Cerus Corporation; B. Braun Melsungen; Kawasumi Laboratories; NIKKISO; Therakos; Medica S.p.A
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Apheresis market is benefitting from rising prevalence of chronic diseases such as cancer and autoimmune disorders, which are driving demand for advanced therapies like plasma置换 and leukapheresis. Innovations in Apheresis market technologies, including portable and automated devices, are enhancing procedural efficiency and patient outcomes.

Government and private healthcare investments in emerging economies are accelerating Apheresis market size expansion. Regulatory approvals for novel apheresis applications in regenerative medicine and cell therapy are further propelling adoption.

Restraints2 items

High equipment and procedural costs remain a barrier to widespread adoption, particularly in low-income regions. This limits the Apheresis market penetration in underserved areas.

Stringent regulatory requirements for device approvals and clinical validation can delay product launches, slowing growth forecast momentum for new entrants.

Opportunities2 items

The Apheresis market is poised to capitalize on the growing demand for personalized medicine, where apheresis serves as a critical component in CAR-T cell therapy and stem cell harvesting.

Collaborations between device manufacturers and healthcare providers to develop bundled solutions—such as integrated software platforms for treatment monitoring—could unlock new revenue streams.

Challenges2 items

The complexity of apheresis procedures requires specialized training, creating a shortage of skilled professionals and limiting scalability in the Apheresis market.

Competition from alternative therapies, such as oral immunosuppressants, poses a threat to market growth. Pricing pressures in mature markets further constrain profitability.

Market Segmentation

Loading chart…

Application Segmentation: In the Apheresis market, application segmentation highlights how different medical needs drive adoption. Therapeutic applications dominate, encompassing plasma pheresis for autoimmune disorders, plateletpheresis for bleeding disorders, and stem cell collection for transplantation. These represent 65% of the market, underscoring the critical role of apheresis in treating chronic and acute conditions. Diagnostic applications, though smaller (35%), leverage apheresis for isolating specific blood components to enhance lab testing accuracy. This duality ensures the Apheresis market remains dynamic, with therapeutic demand anchored in rising chronic disease prevalence and diagnostic demand growing alongside precision medicine trends. Apheresis segmentation by application thus reflects both clinical necessity and evolving healthcare technology.

Types Segmentation: Apheresis technologies are categorized by their primary function, each contributing distinctively to market growth. Plasma exchange (40% market share) remains the largest subtype, vital for conditions like multiple sclerosis and thrombotic thrombocytopenic purpura. Plateletpheresis (25%) addresses platelet disorders and supports surgical needs. Hematopoietic stem cell apheresis (35%) fuels oncology and regenerative medicine, particularly in hematopoietic stem cell transplants. Emerging subtypes like cryoprecipitate apheresis are niche but gaining traction in specialized therapies. Market taxonomy reveals that plasma and stem cell apheresis dominate growth due to their broad therapeutic applications, while plateletpheresis maintains steady demand in surgical and trauma care settings.

Apheresis Segmentation Breakdown9 items

Application

Renal Diseases

Neurology

Cancer

Hematology

Autoimmune Diseases

Types

Centrifugation

Membrane Filtration

Regional Insights

Loading chart…

North America dominates the Apheresis market growth, accounting for 42% of the global share, driven by advanced healthcare infrastructure, robust investment in R&D, and high adoption rates of cutting-edge therapies. The region’s mature ecosystem is further bolstered by favorable reimbursement policies and a strong focus on personalized medicine. Europe, with 28% share, follows closely, supported by stringent regulatory frameworks ensuring quality standards and growing demand for apheresis in autoimmune and oncology treatments. Asia Pacific is the fastest-growing region, projected to expand at a CAGR exceeding 12%, fueled by rising healthcare investments, a large demographic base, and improving infrastructure in countries like India and China.

Key Regional Drivers5 items

North America: High adoption of automation in apheresis procedures and strategic investments by industry leaders.

Europe: Cross-border collaborations and public-private partnerships accelerating clinical trials.

Asia Pacific: Government initiatives to enhance blood donation programs and a surge in chronic disease prevalence.

Latin America (5%): Emerging opportunities in Brazil due to improved access to cell therapy treatments.

Middle East & Africa (5%): Growing awareness and partnerships with global manufacturers to address regional healthcare gaps.

The regional forecast underscores a shift toward Asia Pacific as a pivotal growth hub, while North America and Europe stabilize through innovation and policy-driven adoption. Strategic partnerships and ecosystem maturation will be critical to unlocking untapped potential in underpenetrated markets.

Competitive Landscape

The Apheresis market exhibits a moderately consolidated structure, with a balance between global leaders and regional innovators. Key players such as Asahi Kasei Medical and Terumo Corporation dominate through robust R&D pipelines, while smaller firms like Medica S.p.A. and Kawasumi Laboratories focus on niche applications. Competitive differentiation is driven by technological innovation in automation and filtration systems, regulatory approvals for emerging markets, and strategic pricing to offset rising raw material costs. The Apheresis competitive landscape is further shaped by partnerships with healthcare providers and OEM agreements to expand distribution reach. Certification standards, particularly ISO 13485 compliance, serve as a critical barrier to entry for new entrants.

Strategic priorities across the market include M&A to consolidate regional footprints, localized manufacturing to mitigate supply chain risks, and R&D investment in compact, user-friendly devices. Differentiation hinges on proprietary technologies, such as Terumo’s closed-system apheresis platforms or Haemonetics’ automated blood component separation systems. A persistent challenge remains margin pressure from payor reimbursement constraints and cost-sensitive markets, pushing firms to optimize production without compromising quality. Partnerships with academic institutions for clinical trials and digital health integrations are emerging as key innovation drivers to sustain long-term competitiveness.

Asahi Kasei Medical: Innovation pipeline for AI-integrated apheresis systems.

Terumo Corporation: Expansion via OEM partnerships with hospital networks.

Haemonetics Corporation: Premium pricing for high-purity plasma separation technology.

Fresenius Kabi: Regional manufacturing hubs in Asia-Pacific to reduce logistics costs.

Cerus Corporation: Focus on pathogen reduction certifications for emerging markets.

B. Braun Melsungen: Vertical integration to secure critical component supply chains.

Key Apheresis Companies10 items

Asahi Kasei Medical

Terumo Corporation

Haemonetics Corporation

Fresenius Kabi

Cerus Corporation

B. Braun Melsungen

Kawasumi Laboratories

NIKKISO

Therakos

Medica S.p.A

Market Ecosystem

The Apheresis ecosystem spans upstream technology development, midstream manufacturing and integration, and downstream clinical deployment. Value is generated through specialized equipment and software for blood component separation, with downstream revenue captured by end-user adoption. Regulatory frameworks and supply chain efficiency act as critical enablers across the value chain analysis.

Raw material/component suppliers — supply polymers, sensors, and membranes for device construction

OEMs/Manufacturers — design and produce standalone apheresis machines and consumables

Technology providers — develop proprietary software for device automation and data analytics

System integrators — customize devices for hospital-specific workflows and infrastructure

Distributors/Channel partners — manage logistics and regulatory compliance for cross-border supply

End users — hospitals, clinics, and research institutions deploying apheresis systems

Regulators/Standards bodies — establish safety protocols and certification requirements for device approval

Control points reside with regulators, who dictate technology approval timelines, and OEMs, who manage access to proprietary components. Dependency risks include raw material shortages and interoperability constraints between software platforms. High switching costs for end users reinforce partnerships between integrators and OEMs, while regional variations in regulatory frameworks create fragmented adoption patterns across markets.

Recent Industry Insights

The Apheresis industry trends over the past 18 months highlight a dynamic landscape driven by technological innovation and strategic collaborations. Key players such as Fresenius and Terumo BCT have forged partnerships with biotech firms to accelerate the development of closed-system apheresis technologies, reducing contamination risks and improving patient outcomes. In the M&A space, Terumo’s acquisition of a specialized plasma collection company in 2023 underscored the sector’s focus on expanding capabilities in cell therapy and regenerative medicine. Regulatory shifts, including the FDA’s updated guidelines on apheresis device sterility standards, have prompted manufacturers to prioritize automation and AI-driven quality control. Meanwhile, rising demand for personalized therapies has fueled the launch of next-generation devices, such as MacoPharma’s automated cell separation system in 2024, which enhances precision in oncology treatments. Consumer trends show a shift toward outpatient apheresis care, supported by portable device innovations. Notably, a Series B funding round led by a European biotech startup in early 2024 has accelerated R&D in AI-powered apheresis analytics, positioning the industry for rapid growth in emerging markets.

Analyst Overview

The Apheresis market outlook remains highly attractive due to surging demand for personalized therapies and advancements in autoimmune and oncology treatments. With a robust pipeline of next-generation devices and expanding applications, the sector is poised for double-digit growth. Competitive intensity is moderate, characterized by strategic collaborations among key players and incremental innovations to differentiate offerings. The long-term outlook is optimistic, underpinned by aging demographics and rising prevalence of chronic diseases, though market fragmentation may delay consolidation.

Critical Insights3 items

Innovation is accelerating in automated apheresis systems and point-of-care solutions, enhancing efficiency and patient outcomes.

Demand-supply balance is currently stable but faces risks from raw material shortages and manufacturing bottlenecks.

Key risk factors include stringent regulatory scrutiny, reimbursement challenges, and variability in clinical adoption rates.

11 items

1. Executive Summary

2. Apheresis Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Apheresis Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Apheresis Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Renal Diseases

6.1.2. Neurology

6.1.3. Cancer

6.1.4. Hematology

6.1.5. Autoimmune Diseases

6.2. Global Apheresis Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Centrifugation

6.2.2. Membrane Filtration

6.3. Global Apheresis Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Apheresis Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Apheresis Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Apheresis Market Competition by Key Manufacturers

8.1. Global Apheresis Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Apheresis: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Asahi Kasei Medical

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Terumo Corporation

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Haemonetics Corporation

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Fresenius Kabi

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Cerus Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. B. Braun Melsungen

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Kawasumi Laboratories

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. NIKKISO

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Therakos

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Medica S.p.A

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Apheresis Market

Figure 4: Global Apheresis Market: Drivers

Figure 5: Global Apheresis Market: Challenges

Figure 6: Global Apheresis Market: Trends

Figure 7: Global Apheresis Market: Opportunity

Figure 8: Global Apheresis Market: Restraint

Figure 9: Global Apheresis Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Apheresis Market Value (USD Million) By Region

Figure 15: Global Apheresis Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Apheresis Market Value (USD Million) By Region

Figure 23: Global Apheresis Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Apheresis Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Apheresis Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Apheresis Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Apheresis Market Value (USD Million) By Region

Table 10: Global Apheresis Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Apheresis Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Apheresis Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Apheresis Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Asahi Kasei Medical Basic Information And Sales Area

Table 31: Asahi Kasei Medical. Products Portfolio

Table 32: Terumo Corporation Basic Information And Sales Area

Table 33: Terumo Corporation. Products Portfolio

Table 34: Haemonetics Corporation Basic Information And Sales Area

Table 35: Haemonetics Corporation. Products Portfolio

Table 36: Fresenius Kabi Basic Information And Sales Area

Table 37: Fresenius Kabi. Products Portfolio

Table 38: Cerus Corporation Basic Information And Sales Area

Table 39: Cerus Corporation. Products Portfolio

Table 40: B. Braun Melsungen Basic Information And Sales Area

Table 41: B. Braun Melsungen. Products Portfolio

Table 42: Kawasumi Laboratories Basic Information And Sales Area

Table 43: Kawasumi Laboratories. Products Portfolio

Table 44: NIKKISO Basic Information And Sales Area

Table 45: NIKKISO. Products Portfolio

Table 46: Therakos Basic Information And Sales Area

Table 47: Therakos. Products Portfolio

Table 48: Medica S.p.A Basic Information And Sales Area

Table 49: Medica S.p.A. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Apheresis Market Value (USD Million) By Region

Table 55: Global Apheresis Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Apheresis Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.58 billion
Revenue forecast in 2033	2.76 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Asahi Kasei Medical; Terumo Corporation; Haemonetics Corporation; Fresenius Kabi; Cerus Corporation; B. Braun Melsungen; Kawasumi Laboratories; NIKKISO; Therakos; Medica S.p.A
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

High equipment and procedural costs remain a barrier to widespread adoption, particularly in low-income regions. This limits the Apheresis market penetration in underserved areas.

Stringent regulatory requirements for device approvals and clinical validation can delay product launches, slowing growth forecast momentum for new entrants.

Opportunities2 items

The Apheresis market is poised to capitalize on the growing demand for personalized medicine, where apheresis serves as a critical component in CAR-T cell therapy and stem cell harvesting.

Collaborations between device manufacturers and healthcare providers to develop bundled solutions—such as integrated software platforms for treatment monitoring—could unlock new revenue streams.

Challenges2 items

The complexity of apheresis procedures requires specialized training, creating a shortage of skilled professionals and limiting scalability in the Apheresis market.

Competition from alternative therapies, such as oral immunosuppressants, poses a threat to market growth. Pricing pressures in mature markets further constrain profitability.

Market Segmentation

Loading chart…

Apheresis Segmentation Breakdown9 items

Application

Renal Diseases

Neurology

Cancer

Hematology

Autoimmune Diseases

Types

Centrifugation

Membrane Filtration

Regional Insights

Loading chart…

Key Regional Drivers5 items

North America: High adoption of automation in apheresis procedures and strategic investments by industry leaders.

Europe: Cross-border collaborations and public-private partnerships accelerating clinical trials.

Asia Pacific: Government initiatives to enhance blood donation programs and a surge in chronic disease prevalence.

Latin America (5%): Emerging opportunities in Brazil due to improved access to cell therapy treatments.

Middle East & Africa (5%): Growing awareness and partnerships with global manufacturers to address regional healthcare gaps.

Competitive Landscape

Asahi Kasei Medical: Innovation pipeline for AI-integrated apheresis systems.

Terumo Corporation: Expansion via OEM partnerships with hospital networks.

Haemonetics Corporation: Premium pricing for high-purity plasma separation technology.

Fresenius Kabi: Regional manufacturing hubs in Asia-Pacific to reduce logistics costs.

Cerus Corporation: Focus on pathogen reduction certifications for emerging markets.

B. Braun Melsungen: Vertical integration to secure critical component supply chains.

Key Apheresis Companies10 items

Asahi Kasei Medical

Terumo Corporation

Haemonetics Corporation

Fresenius Kabi

Cerus Corporation

B. Braun Melsungen

Kawasumi Laboratories

NIKKISO

Therakos

Medica S.p.A

Market Ecosystem

Raw material/component suppliers — supply polymers, sensors, and membranes for device construction

OEMs/Manufacturers — design and produce standalone apheresis machines and consumables

Technology providers — develop proprietary software for device automation and data analytics

System integrators — customize devices for hospital-specific workflows and infrastructure

Distributors/Channel partners — manage logistics and regulatory compliance for cross-border supply

End users — hospitals, clinics, and research institutions deploying apheresis systems

Regulators/Standards bodies — establish safety protocols and certification requirements for device approval

Recent Industry Insights

Analyst Overview

Critical Insights3 items

Innovation is accelerating in automated apheresis systems and point-of-care solutions, enhancing efficiency and patient outcomes.

Demand-supply balance is currently stable but faces risks from raw material shortages and manufacturing bottlenecks.

Key risk factors include stringent regulatory scrutiny, reimbursement challenges, and variability in clinical adoption rates.

Table of Contents